ÂÜÀòÂÒÂ×

Danielle Andruskiwec has a diverse and extensive work experience in the field of compensation and HRIS. Danielle is currently employed at Intercept Pharmaceuticals as the Director of Compensation & HRIS since December 2022. Prior to this role, they worked as a Senior Manager of Compensation & HRIS at Rue Gilt Groupe from July 2021 to December 2022.

Before joining Rue Gilt Groupe, Danielle spent a significant portion of their career at Vertex Pharmaceuticals. At Vertex Pharmaceuticals, they held two positions: Compensation Manager from February 2020 to May 2021 and Senior Compensation Analyst from December 2018 to February 2020.

Danielle's earlier career includes roles at athenahealth, where they worked as a Senior Compensation and Analytics Associate (Sr. Compensation Analyst) from September 2017 to December 2018, and as a Compensation and Analytics Associate (Compensation Analyst II) from July 2015 to August 2017.

Prior to their time at athenahealth, Danielle worked as a Compensation Analyst at Boston University from March 2014 to July 2015. Danielle began their career as a Compensation Analyst at Kenexa, an IBM Company, from May 2012 to March 2014.

Danielle's earliest position was at State Street, where they worked as a NAV Specialist Associate 1 from April 2011 to May 2012. Throughout their career, Danielle has gained extensive knowledge and expertise in the areas of compensation, HRIS, and analytics.

Danielle Andruskiwec obtained a Bachelor's degree in Mathematics from Emmanuel College (Boston) from 2006 to 2010. Prior to that, they attended Amity Regional High School from 2002 to 2006, although no specific degree or field of study was mentioned for this period. Additionally, Danielle Andruskiwec holds additional certifications, including a Global Remuneration Professional (GRP) certification obtained from WorldatWork in December 2014 and a Certified Compensation Professional (CCP) certification obtained from the same institution in November 2013.